Bartholomew, Tyler S. http://orcid.org/0000-0002-9384-0812
Plesons, Marina
Serota, David P.
Alonso, Elizabeth
Metsch, Lisa R.
Feaster, Daniel J.
Ucha, Jessica
Suarez, Edward Jr.
Forrest, David W.
Chueng, Teresa A.
Ciraldo, Katrina
Brooks, Jimmie
Smith, Justin D.
Barocas, Joshua A.
Tookes, Hansel E.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services
https://doi.org/10.1186/s13722-024-00447-9
Funding for this research was provided by:
National Institute on Drug Abuse (1R01DA058352-01)
Article History
Received: 26 September 2023
Accepted: 13 February 2024
First Online: 25 March 2024
Declarations
:
: The CHARIOT trial was approved by the IRB of the University of Miami on 4/3/2023 IRB#20230061. The University of Miami IRB serves as the single IRB for the trial. All participants will provide written informed consent prior to study participation.
: The consent materials are available from the corresponding author on request.
: HET and TSB report research grants from Gilead Sciences and ViiV. JAB receives consulting fees from eMed. MP, DPS, EA, LRM, DJF, JU, ES, DEF, TC, KC, and JS declare that they have no competing interests.